SEC Form 4 · accession 0001192482-16-000727
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Sherrill Neff
Director
Period of report
Oct 5, 2016
Accepted (ET)
Oct 7, 2016 · 8:33 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2016 | J | 1,000,000 | $0.00 | D | 2,527,154 | I | By Quaker BioVentures II, L.P. |
| Common Stock | Oct 5, 2016 | J | 2,488 | $0.00 | A | 2,488 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro rata distribution of the shares to the partners of Quaker BioVentures II, L.P. ("Quaker") for no consideration.
- F2Represents a pro rata distribution of the shares to the Reporting Person by Quaker. These shares were included in shares previously reported as indirectly owned by the Reporting Person in prior Forms 4, and this change in the form of beneficial ownership from indirect to direct is exempt from Section 16 by virtue of Rule 16a-13.